Tunisia’s Ben Jafar to Asharq Al-Awsat: Transfering Legislative Powers Temporarily to Govt is Constitutional

Former president of Tunisia's National Constituent Assembly Mustafa Ben Jafar (File photo: Reuters)
Former president of Tunisia's National Constituent Assembly Mustafa Ben Jafar (File photo: Reuters)
TT

Tunisia’s Ben Jafar to Asharq Al-Awsat: Transfering Legislative Powers Temporarily to Govt is Constitutional

Former president of Tunisia's National Constituent Assembly Mustafa Ben Jafar (File photo: Reuters)
Former president of Tunisia's National Constituent Assembly Mustafa Ben Jafar (File photo: Reuters)

Tunisia’s Former President of the Constituent Assembly Mustapha Ben Jafar argued that transfering legislative powers temporarily to Prime Minister Elyes Fakhfakh, according to Chapter 70 of the constitution, is a “legal political measure imposed by the exceptional stage that the country and the world are going through.”

Ben Jafar said the step was equal to President Kais Saied’s usage of Chapter 80 which considers the country in a dangerous state that requires exceptional measures.

In an interview with Asharq al-Awsat, Ben Jafar expected the political parties that opposed this measure to change their position and accept the comprehensive rescue and intervention plan announced by the government and supported by the president and speaker.

He also indicated that the current stage amid the coronavirus pandemic requires the government to pass laws and decisions even if they contradict with the popular opinion.

In 2011, interim President Fouad Mebazaa declared a state of emergency that enabled him to run the country through decrees and orders, he noted.

Ben Jafar downplayed the political repercussions reported in the Tunisian and international media about deep differences between the three presidents.

He indicated that the disagreements between Saied, Fakhfakh, and Speaker Rached Ghannouchi are secondary and merely procedural over some powers.

Ben Jafar said statements by officials close to the three presidents confirm their keenness over joint work, especially during this stage where the country and the world are facing health risks and signs of economic, social, political, and security crises.

For his part, Ben Jafar acknowledged the existence of “an issue of confidence” between some politicians, especially that the majority of citizens are now disappointed given that the reforms demanded by the youth of the revolution 10 years ago have not been implemented.

Asked about the government of Fakhfakh, Ben Jafar considered that the cabinet is the most democratic in the contemporary history of Tunisia because it includes well-known human rights and democracy figures.

He admitted that a large segment of the people, especially its youth, do not trust the authorities because of their lack of participation in public affairs and political life.

Ben Jafar expected coordination between the three presidents to improve immediately after the coronavirus pandemic has subsided, especially that everyone had discovered the efficacy of the latest decisions including lockdown, closing cafes, clubs, mosques, and airports.



Hevolution CEO Discusses Career in Innovation, Medicine, and Business

Dr. Mehmood Khan, CEO of the Hevolution Foundation
Dr. Mehmood Khan, CEO of the Hevolution Foundation
TT

Hevolution CEO Discusses Career in Innovation, Medicine, and Business

Dr. Mehmood Khan, CEO of the Hevolution Foundation
Dr. Mehmood Khan, CEO of the Hevolution Foundation

Dr. Mehmood Khan, CEO of the Hevolution Foundation, the largest philanthropy organization funding aging medicine in the world, expressed that receiving Saudi citizenship will boost his scientific and practical capabilities.
He said this new status will help him advance his research, especially in addressing aging.
This comes as part of a recent royal decree granting Saudi citizenship to several notable scholars, doctors, researchers, and innovators.
“Our Chairman, his Royal Highness (Crown Prince Mohammed bin Salman), has very high expectations of our work and the impact we need to do; We were created in part because of his vision,” Khan told Asharq Al-Awsat.
“Living up to the expectations and challenges we get faced with is itself exciting, but it is challenging,” revealed Khan, affirming that Hevolution’s team is “up to that task.”
Khan, who has experience in both corporate and medical fields, told Asharq Al-Awsat that his work across academic, public, and private sectors has been a continuous learning process, with each area enhancing the others.
According to the CEO, these industries are interconnected, and combining their strengths often leads to the best solutions.
This insight inspired the Hevolution initiative, which brings together the scientific community, NGOs, pharmaceutical companies, policymakers, academia, biotech firms, CEOs, and others to promote healthy aging.
Khan highlighted the value of integrating insights from different sectors.
Academia provides detailed research, the public sector offers insights on population health and regulations, and the corporate world brings innovation and efficiency, explained Khan, adding that by merging these perspectives, the world can tackle complex health challenges more effectively.
“We’ve been working through, and are now investing, funding and partnering with over 200 scientists around the world, and over 150 different university labs,” said Khan.
Hevolution uses this integrated approach to advance healthy aging.
This initiative embodies my passion for addressing major challenges and offers a significant opportunity to make a global impact.
Khan talked about the first $400 million commitment Hevolution made in the last 23 months, calling it “unprecedented.”
“There has never been a non-profit organization in the world that has gone from not existing to now becoming the largest philanthropy funding aging biology and medicine in the world,” affirmed Khan.
Khan stressed that work at Hevolution not only pushes scientific boundaries but also promotes cross-sector collaboration to improve global health outcomes.
Since Khan’s early days in medical school, he’s been deeply interested in nutrition and population health, which was an unconventional focus back then. This journey set the foundation for his later work in community health.
Khan’s time as an endocrinology faculty member at the Mayo Clinic was crucial. He led programs on diabetes, endocrine diseases, metabolism, and nutrition, which strengthened his expertise in designing disease prevention systems.
In the private sector, Khan took on a key role at Takeda Pharmaceutical as the global head of R&D, which shaped his approach to innovative healthcare solutions.
At PepsiCo, as Chief Scientific Officer, he learned crucial principles of scale, impact, transformation, and tackling global challenges.
As CEO of Hevolution, Khan uses all his professional experience to advance the foundation’s mission of developing health sciences to address age-related diseases.
Khan serves on the boards of Reckitt Benckiser and the Saudi Research, Development, and Innovation Authority (RDIA).
He is the CEO of Life Biosciences, a member of Saudi Arabia’s biotechnology strategy committee, and the chair of the advanced technology visiting committee at the US National Institute of Standards and Technology (NIST).
Khan told Asharq Al-Awsat that he feels honored to have recently become a Saudi citizen by royal decree, while also holding dual US and UK citizenship. This helps him lead Hevolution effectively and work closely with international partners.
Khan commented on his recent Saudi citizenship, saying that in addition to feeling honored to receive Saudi citizenship by royal decree, alongside other distinguished individuals, this recognition is a great privilege.
Being a Saudi citizen, as per Khan, is a significant milestone and acknowledges the progress in his work in aging science and global health. It also strengthens Khan’s commitment to the work at Hevolution.
Khan noted that this new status enhances his ability to build relationships and collaborate within the Kingdom and internationally. It offers a deeper connection with the local community and better opportunities to engage with policymakers and leaders.
He also said that this recognition boosts Hevolution’s global presence and credibility, making the foundation’s collaborations with international scientists and business leaders stronger. It positions Hevolution as a key player in addressing age-related diseases.
Khan emphasized that this honor reflects the hard work and innovation of Hevolution’s entire team.
The CEO said that it was collective efforts that have made this achievement possible.
Khan also said he is excited to engage more deeply with the scientific and medical community in the Kingdom, adding that his new citizenship helps him contribute to Vision 2030 and the national biotechnology strategy, promoting innovation and attracting top global talent.